AB012. Brachytherapy for localized prostate cancer
Podium Lecture

AB012. Brachytherapy for localized prostate cancer

Yong Xu, Yong Yang

Department of Urology, the General Hospital of PLA, Beijing 100853, China


Background: To evaluate the security and effect of brachytherapy for localized prostate cancer.

Methods: Forty five patients with Tl–T2 prostate cancer were treated with real-time transperineal ultrasound-guide 125I seeds prostate implantation.

Results: The median operation time was 90 min, the median number of I seeds used was 56. The follow up time was 12–48 months, the cases of PSA <1 µg/L were 29, PSA 1–2 µg/L were 11 and PSA ≥2 µg/L were 5.

Conclusions: Brachytherapy for localized prostate cancer is safe and effective.

Keywords: Brachytherapy; prostate; cancer


doi: 10.21037/tau.2016.s012


Cite this abstract as: Xu Y, Yang Y. Brachytherapy for localized prostate cancer. Transl Androl Urol 2016;5(Suppl 1):AB012. doi: 10.21037/tau.2016.s012

Download Citation